AmeriPath $210 million 10-year notes talked at 10¾% area, pricing Thursday afternoon

By Paul A. Harris

St. Louis, March 12 - AmeriPath Inc.'s $210 million of 10-year senior subordinated notes (expected ratings B3/B-) are talked at a yield in the 10¾% area, according to a syndicate source.

The deal is expected to price Thursday afternoon, the source added.

Credit Suisse First Boston and Deutsche Bank Securities Inc. are joint bookrunners.

The notes are non-callable for five years.

Proceeds will be used to help fund the LBO of the company by Welsh, Carson, Anderson & Stowe, to be completed before April 30, 2003 - a transaction valued at $839.4 million.

AmeriPath is a Riviera Beach, Fla. provider of cancer diagnostics, genomic, and related information services

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.